GoodRx Holdings (GDRX) Shares Outstanding (2019 - 2026)

GoodRx Holdings has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $337.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 6.44% year-over-year to $337.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $337.6 million (down 6.44% YoY) and the FY2025 annual result came in at $341.1 million, down 10.91% from the prior year.
• Shares Outstanding (Entity) declined to $337.6 million in Q1 2026 per GDRX's latest filing, from $341.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $398.4 million in Q3 2023 and troughed at $337.6 million in Q1 2026.
• A 5-year average of $377.8 million and a median of $382.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) rose 0.94% in 2022, then declined 10.91% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $397.0 million in 2022, then fell by 0.74% to $394.1 million in 2023, then dropped by 2.86% to $382.8 million in 2024, then decreased by 10.91% to $341.1 million in 2025, then retreated by 1.02% to $337.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $337.6 million, $341.1 million, and $341.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.